Antimicrobial Medical Device Coatings Market Report 2026

The antimicrobial medical device coatings market size has grown rapidly in recent years. It will grow from $2.98 billion in 2025 to $3.48 billion in 2026 at a compound annual growth rate (CAGR) of 16.7%. The growth in the historic period can be attributed to increasing hospital-acquired infection concerns, rising adoption of implantable medical devices, growth in surgical procedures, advancements in coating material science, expansion of healthcare infrastructure.

The antimicrobial medical device coatings market size is expected to see rapid growth in the next few years. It will grow to $6.47 billion in 2030 at a compound annual growth rate (CAGR) of 16.8%. The growth in the forecast period can be attributed to increasing regulatory focus on infection prevention, rising demand for advanced implant coatings, expansion of minimally invasive surgeries, growing investments in medical device innovation, increasing adoption of antimicrobial polymers. Major trends in the forecast period include increasing adoption of infection-resistant medical devices, rising use of silver and polymer-based coatings, growing focus on long-term antimicrobial efficacy, expansion of coatings for implantable devices, enhanced emphasis on surface durability and biocompatibility.

The rising number of surgeries is expected to drive the growth of the antimicrobial medical device coatings market going forward. Surgery involves the removal, repair, or examination of a bodily component to treat or diagnose a condition. Antimicrobial coatings provide long-lasting protection against microbial growth, making medical devices easier to clean and reducing the risk of cross-contamination. For example, in July 2023, the National UK Eye Care Statistics Survey, conducted by the Well-being of Future Generations Act (WFG), a UK-based government agency, reported an estimated 16,510 cataract admissions in 2022-23, a 23.7% increase from the previous year. Consequently, the increasing number of surgeries is fueling the antimicrobial medical device coatings market.

Key companies in the antimicrobial medical device coatings market are developing advanced solutions, such as innovative surface-active coatings, to prevent microbial growth, extend device longevity, and enhance patient safety. These specialized coatings actively interact with a device’s surface to inhibit microbial growth, improve biocompatibility, and boost overall performance. For instance, in November 2025, BioInteractions Limited, a UK-based medical equipment manufacturer, launched a new category of medical device coatings called Surface-Active Materials (SAMs). These coatings offer high durability, lubricity, and safety without leaching, designed to support the growing demand for miniaturized, minimally invasive medical devices. The first technology in this category, Assist, is a single-layer coating providing instant lubricity, long-term durability under high stress, and ultra-low particulate generation, enhancing device reliability in complex clinical settings.

In November 2025, GTCR LLC, a US-based investment firm specializing in healthcare technology, acquired Surmodics, Inc. for $627 million. This acquisition enables GTCR to strengthen its position in the medical-device coatings industry by combining Surmodics’ advanced surface-coating capabilities with its existing portfolio, enhancing technological expertise and expanding market reach. Surmodics, Inc., based in the US, specializes in advanced surface-modification and drug-delivery coatings - including hydrophilic, hemocompatible, and drug-delivery solutions - for intravascular medical devices and related in vitro diagnostic components.

Major companies operating in the antimicrobial medical device coatings market are AST Products Inc., BioInteractions Ltd., Covalon Technologies Ltd., Koninklijke DSM N.V., Hydromer Inc., BASF SE, Sciessent LLC, DuPont de Nemours Inc., Kraton Corporation, Sono-Tek Corporation, Microban International Ltd., Specialty Coating Systems Inc., Dow Inc., PPG Industries Inc., 3M Company, Becton Dickinson and Company, Cardinal Health Inc., Johnson & Johnson, Medtronic plc, Stryker Corporation, Boston Scientific Corporation, Cook Medical LLC, C.R. Bard Inc., Teleflex Incorporated, Zimmer Biomet Holdings Inc., Smith & Nephew plc, Olympus Corporation, Abbott Laboratories, Terumo Corporation, Fresenius Medical Care AG & Co. KGaA, Getinge AB, Hill-Rom Holdings Inc., Integra LifeSciences Holdings Corporation, Mölnlycke Health Care AB.

North America was the largest region in the antimicrobial medical device coatings market in 2025. Europe was the second-largest market in the antimicrobial medical device coatings market. The regions covered in the antimicrobial medical device coatings market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the antimicrobial medical device coatings market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The antimicrobial medical device coatings market consists of sales of non-metallic antimicrobial medical device coating including polymeric and organic coatings. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.